University at Buffalo researcher Jonathan Lovell will receive a five-year, $1.9 million grant to work on a new nanotechnology that could greatly improve how doctors treat and understand cancer, the National Institutes of Health announced Monday.
The grant is one of 15 awarded nationwide under NIH’s Early Independence Award program that funds high-risk, high-reward research. It helps position UB, which has nationally ranked schools in engineering and medicine, as well as a longstanding partnership with Roswell Park Cancer Institute, at the forefront of cancer research.
“This award will enable UB to continue what it does best: conduct groundbreaking research that serves society while educating the leaders of tomorrow,” said Liesl Folks, dean of the UB’s School of Engineering and Applied Sciences. “Specifically, it could help improve how we treat cancer and potentially alleviate pain that millions of people and their families endure.”